[D3-A2] Bioanalysis in Cellular and Gene Therapies: Standardization and Implementation

1:25 PM - 1:55 PM JST(4:25 AM - 4:55 AM UTC)

[D3-A2-01] Overview of the ICH S12 Guideline "Nonclinical Biodistribution Considerations for Gene Therapy Products"

*Daisuke Temmizu^1,2 (1. Japan Pharmaceutical Manufacturers Association, 2. Bristol-Myers Squibb K.K.)

Password required to view

Log in

or